ITRASPORAX 200 CAP delivers a higher dose of Itraconazole, a broad-spectrum triazole antifungal agent known for its efficacy in treating a wide range of fungal infections. It inhibits fungal cytochrome P450 enzymes, impairing ergosterol synthesis — a key component of fungal cell membranes — leading to fungal cell death.

ITRASPORAX 200 CAP is prescribed when a stronger, more concentrated antifungal treatment is required, particularly in:

Systemic fungal infections like histoplasmosis, aspergillosis, and blastomycosis

Fungal infections of nails (onychomycosis) and skin

Oral, esophageal, and vaginal candidiasis

Fungal infections resistant to topical treatment

Fungal infections in immunocompromised patients

With superior tissue penetration and a long half-life, ITRASPORAX 200 CAP ensures sustained therapeutic levels in the body. It is especially effective in pulse therapy, where higher intermittent dosing is required for difficult-to-treat infections like nail fungus.

This product is manufactured under international standards, including WHO-GMP, ISO, and DCGI compliance. It is suitable for bulk orders, private labeling, and registration in multiple regulated and semi-regulated markets across the globe, exclusively via BLUEPILL EXPRESS.

Contains Itraconazole 200 mg – high-potency antifungal

Designed for severe and systemic fungal infections

Suitable for pulse therapy and long-duration treatments

Excellent tissue penetration and antifungal activity

Manufactured under WHO-GMP certified facilities

Offered by BLUEPILL EXPRESS for global export and contract manufacturing

Flexible packaging and documentation support for international partners